A focused investor in MedTech.

Surgical instruments Sketch-to-Scale®, since 1920. From CAD design and prototyping to robot-assisted series production — everything in one hand, made in Germany. One of Germany's fastest-growing mid-size companies in 2026. What stands out: a manufacturing process where quality is lived, not explained. At Hipp & Sohn, regulatory work is never left to the last hour.

Digital respiratory therapy for COPD and asthma — app, coaching, symptom diary, ZPP-certified, designed for statutory reimbursement. A clinically rigorous product that doesn't shy away from the path through payers and approval. That's exactly where IPP can and wants to contribute.

Digital care programme for chronic inflammatory bowel disease — Crohn's disease and ulcerative colitis. ZPP-certified, up to 100% covered by statutory health insurance. A small team that doesn't work around regulatory obstacles — it solves them. That's rare, and that's exactly what makes it interesting.

Accelerator and ecosystem for health startups in the Ruhr region — supporting teams through build and growth phases. Direct access to early-stage companies before the regulatory groundwork gets laid the wrong way. IPP is present here because good regulatory practice has to start early.

Nanotechnology CDMO: dendritic nanocarriers, contract synthesis, GMP small-batch manufacturing for pharma and cosmetics. Deep technology expertise combined with a regulatory maturity that is unusually well-developed for a Berlin deeptech company of this size.